TGA approves Prometrium (progesterone)

7 July 2016 - The TGA has approved Besins Healthcare's Prometrium (progesterone).

The TGA approved Prometrium on 20 June 2016 (not 10 July 2016) for use in women with menstrual abnormalities or secondary amenorrhoea due to normogonadotrophic amenorrhoea and for adjunctive use with an oestrogen for hormone replacement therapy in postmenopausal women with an intact uterus.

View Prometrium PI

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , Australia